nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanabenz—CYP1A2—Carmustine—malignant glioma	0.62	1	CbGbCtD
Guanabenz—Burning sensation—Carmustine—malignant glioma	0.00888	0.0241	CcSEcCtD
Guanabenz—Lung disorder—Temozolomide—malignant glioma	0.00843	0.0229	CcSEcCtD
Guanabenz—Accidental injury—Carmustine—malignant glioma	0.00697	0.0189	CcSEcCtD
Guanabenz—Thinking abnormal—Carmustine—malignant glioma	0.00674	0.0183	CcSEcCtD
Guanabenz—Leukocytosis—Carmustine—malignant glioma	0.00657	0.0178	CcSEcCtD
Guanabenz—Neck pain—Carmustine—malignant glioma	0.00625	0.0169	CcSEcCtD
Guanabenz—Musculoskeletal pain—Temozolomide—malignant glioma	0.00604	0.0164	CcSEcCtD
Guanabenz—Skin exfoliation—Carmustine—malignant glioma	0.00589	0.016	CcSEcCtD
Guanabenz—Skin exfoliation—Temozolomide—malignant glioma	0.00569	0.0154	CcSEcCtD
Guanabenz—Mental disability—Carmustine—malignant glioma	0.00535	0.0145	CcSEcCtD
Guanabenz—Mental disability—Temozolomide—malignant glioma	0.00517	0.014	CcSEcCtD
Guanabenz—Diabetes mellitus—Carmustine—malignant glioma	0.00515	0.014	CcSEcCtD
Guanabenz—Injury—Carmustine—malignant glioma	0.00487	0.0132	CcSEcCtD
Guanabenz—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00459	0.0124	CcSEcCtD
Guanabenz—Hyponatraemia—Carmustine—malignant glioma	0.0045	0.0122	CcSEcCtD
Guanabenz—Face oedema—Carmustine—malignant glioma	0.00432	0.0117	CcSEcCtD
Guanabenz—Face oedema—Temozolomide—malignant glioma	0.00418	0.0113	CcSEcCtD
Guanabenz—Liver function test abnormal—Carmustine—malignant glioma	0.00414	0.0112	CcSEcCtD
Guanabenz—Hypokalaemia—Carmustine—malignant glioma	0.00408	0.0111	CcSEcCtD
Guanabenz—Dehydration—Temozolomide—malignant glioma	0.00403	0.0109	CcSEcCtD
Guanabenz—Dry skin—Temozolomide—malignant glioma	0.00397	0.0108	CcSEcCtD
Guanabenz—Hypokalaemia—Temozolomide—malignant glioma	0.00394	0.0107	CcSEcCtD
Guanabenz—Breast disorder—Temozolomide—malignant glioma	0.00391	0.0106	CcSEcCtD
Guanabenz—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.0039	0.0106	CcSEcCtD
Guanabenz—Abdominal distension—Temozolomide—malignant glioma	0.00377	0.0102	CcSEcCtD
Guanabenz—Hyperglycaemia—Carmustine—malignant glioma	0.00349	0.00947	CcSEcCtD
Guanabenz—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00348	0.00943	CcSEcCtD
Guanabenz—Weight increased—Temozolomide—malignant glioma	0.0034	0.00924	CcSEcCtD
Guanabenz—Weight decreased—Temozolomide—malignant glioma	0.00338	0.00918	CcSEcCtD
Guanabenz—Hyperglycaemia—Temozolomide—malignant glioma	0.00337	0.00915	CcSEcCtD
Guanabenz—Infestation—Temozolomide—malignant glioma	0.00334	0.00905	CcSEcCtD
Guanabenz—Infestation NOS—Temozolomide—malignant glioma	0.00334	0.00905	CcSEcCtD
Guanabenz—Haemoglobin—Carmustine—malignant glioma	0.00311	0.00845	CcSEcCtD
Guanabenz—Haemorrhage—Carmustine—malignant glioma	0.0031	0.00841	CcSEcCtD
Guanabenz—Oedema peripheral—Carmustine—malignant glioma	0.00305	0.00828	CcSEcCtD
Guanabenz—Connective tissue disorder—Carmustine—malignant glioma	0.00305	0.00826	CcSEcCtD
Guanabenz—Haemoglobin—Temozolomide—malignant glioma	0.00301	0.00816	CcSEcCtD
Guanabenz—Haemorrhage—Temozolomide—malignant glioma	0.00299	0.00812	CcSEcCtD
Guanabenz—Oedema peripheral—Temozolomide—malignant glioma	0.00295	0.008	CcSEcCtD
Guanabenz—Connective tissue disorder—Temozolomide—malignant glioma	0.00294	0.00798	CcSEcCtD
Guanabenz—Eye disorder—Carmustine—malignant glioma	0.0029	0.00786	CcSEcCtD
Guanabenz—Erythema multiforme—Temozolomide—malignant glioma	0.00283	0.00768	CcSEcCtD
Guanabenz—Eye disorder—Temozolomide—malignant glioma	0.0028	0.00759	CcSEcCtD
Guanabenz—Tinnitus—Temozolomide—malignant glioma	0.00279	0.00757	CcSEcCtD
Guanabenz—Immune system disorder—Temozolomide—malignant glioma	0.0027	0.00734	CcSEcCtD
Guanabenz—Mediastinal disorder—Temozolomide—malignant glioma	0.0027	0.00732	CcSEcCtD
Guanabenz—Erythema—Carmustine—malignant glioma	0.0027	0.00732	CcSEcCtD
Guanabenz—Malnutrition—Carmustine—malignant glioma	0.0027	0.00732	CcSEcCtD
Guanabenz—Chills—Temozolomide—malignant glioma	0.00269	0.00729	CcSEcCtD
Guanabenz—Back pain—Carmustine—malignant glioma	0.00261	0.00708	CcSEcCtD
Guanabenz—Malnutrition—Temozolomide—malignant glioma	0.00261	0.00707	CcSEcCtD
Guanabenz—Erythema—Temozolomide—malignant glioma	0.00261	0.00707	CcSEcCtD
Guanabenz—Vision blurred—Carmustine—malignant glioma	0.00254	0.0069	CcSEcCtD
Guanabenz—Back pain—Temozolomide—malignant glioma	0.00252	0.00684	CcSEcCtD
Guanabenz—Anaemia—Carmustine—malignant glioma	0.00249	0.00676	CcSEcCtD
Guanabenz—Agitation—Carmustine—malignant glioma	0.00248	0.00672	CcSEcCtD
Guanabenz—Vision blurred—Temozolomide—malignant glioma	0.00246	0.00666	CcSEcCtD
Guanabenz—Ill-defined disorder—Temozolomide—malignant glioma	0.00242	0.00656	CcSEcCtD
Guanabenz—Leukopenia—Carmustine—malignant glioma	0.00241	0.00655	CcSEcCtD
Guanabenz—Anaemia—Temozolomide—malignant glioma	0.00241	0.00654	CcSEcCtD
Guanabenz—Agitation—Temozolomide—malignant glioma	0.0024	0.0065	CcSEcCtD
Guanabenz—Angioedema—Temozolomide—malignant glioma	0.00238	0.00646	CcSEcCtD
Guanabenz—Malaise—Temozolomide—malignant glioma	0.00235	0.00638	CcSEcCtD
Guanabenz—Leukopenia—Temozolomide—malignant glioma	0.00233	0.00633	CcSEcCtD
Guanabenz—Hypertension—Carmustine—malignant glioma	0.00233	0.00632	CcSEcCtD
Guanabenz—Myalgia—Carmustine—malignant glioma	0.0023	0.00623	CcSEcCtD
Guanabenz—Chest pain—Carmustine—malignant glioma	0.0023	0.00623	CcSEcCtD
Guanabenz—Anxiety—Carmustine—malignant glioma	0.00229	0.00621	CcSEcCtD
Guanabenz—Cough—Temozolomide—malignant glioma	0.00227	0.00617	CcSEcCtD
Guanabenz—Hypertension—Temozolomide—malignant glioma	0.00225	0.0061	CcSEcCtD
Guanabenz—Confusional state—Carmustine—malignant glioma	0.00222	0.00602	CcSEcCtD
Guanabenz—Arthralgia—Temozolomide—malignant glioma	0.00222	0.00602	CcSEcCtD
Guanabenz—Myalgia—Temozolomide—malignant glioma	0.00222	0.00602	CcSEcCtD
Guanabenz—Anxiety—Temozolomide—malignant glioma	0.00221	0.006	CcSEcCtD
Guanabenz—Oedema—Carmustine—malignant glioma	0.0022	0.00597	CcSEcCtD
Guanabenz—Discomfort—Temozolomide—malignant glioma	0.00219	0.00595	CcSEcCtD
Guanabenz—Infection—Carmustine—malignant glioma	0.00219	0.00593	CcSEcCtD
Guanabenz—Dry mouth—Temozolomide—malignant glioma	0.00217	0.00589	CcSEcCtD
Guanabenz—Thrombocytopenia—Carmustine—malignant glioma	0.00216	0.00585	CcSEcCtD
Guanabenz—Tachycardia—Carmustine—malignant glioma	0.00215	0.00583	CcSEcCtD
Guanabenz—Confusional state—Temozolomide—malignant glioma	0.00215	0.00582	CcSEcCtD
Guanabenz—Oedema—Temozolomide—malignant glioma	0.00213	0.00577	CcSEcCtD
Guanabenz—Infection—Temozolomide—malignant glioma	0.00211	0.00573	CcSEcCtD
Guanabenz—Anorexia—Carmustine—malignant glioma	0.0021	0.00569	CcSEcCtD
Guanabenz—Nervous system disorder—Temozolomide—malignant glioma	0.00209	0.00566	CcSEcCtD
Guanabenz—Thrombocytopenia—Temozolomide—malignant glioma	0.00208	0.00565	CcSEcCtD
Guanabenz—Skin disorder—Temozolomide—malignant glioma	0.00207	0.00561	CcSEcCtD
Guanabenz—Hypotension—Carmustine—malignant glioma	0.00206	0.00558	CcSEcCtD
Guanabenz—Anorexia—Temozolomide—malignant glioma	0.00203	0.0055	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00201	0.00544	CcSEcCtD
Guanabenz—Paraesthesia—Carmustine—malignant glioma	0.00198	0.00536	CcSEcCtD
Guanabenz—Dyspnoea—Carmustine—malignant glioma	0.00196	0.00532	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00194	0.00526	CcSEcCtD
Guanabenz—Decreased appetite—Carmustine—malignant glioma	0.00191	0.00519	CcSEcCtD
Guanabenz—Paraesthesia—Temozolomide—malignant glioma	0.00191	0.00518	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Carmustine—malignant glioma	0.0019	0.00516	CcSEcCtD
Guanabenz—Dyspnoea—Temozolomide—malignant glioma	0.0019	0.00514	CcSEcCtD
Guanabenz—Pain—Carmustine—malignant glioma	0.00188	0.00511	CcSEcCtD
Guanabenz—Constipation—Carmustine—malignant glioma	0.00188	0.00511	CcSEcCtD
Guanabenz—Dyspepsia—Temozolomide—malignant glioma	0.00187	0.00508	CcSEcCtD
Guanabenz—Decreased appetite—Temozolomide—malignant glioma	0.00185	0.00502	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00184	0.00498	CcSEcCtD
Guanabenz—Fatigue—Temozolomide—malignant glioma	0.00183	0.00498	CcSEcCtD
Guanabenz—Constipation—Temozolomide—malignant glioma	0.00182	0.00493	CcSEcCtD
Guanabenz—Pain—Temozolomide—malignant glioma	0.00182	0.00493	CcSEcCtD
Guanabenz—Feeling abnormal—Carmustine—malignant glioma	0.00181	0.00492	CcSEcCtD
Guanabenz—Gastrointestinal pain—Carmustine—malignant glioma	0.0018	0.00488	CcSEcCtD
Guanabenz—Feeling abnormal—Temozolomide—malignant glioma	0.00175	0.00476	CcSEcCtD
Guanabenz—Abdominal pain—Carmustine—malignant glioma	0.00174	0.00472	CcSEcCtD
Guanabenz—Body temperature increased—Carmustine—malignant glioma	0.00174	0.00472	CcSEcCtD
Guanabenz—Gastrointestinal pain—Temozolomide—malignant glioma	0.00174	0.00472	CcSEcCtD
Guanabenz—Urticaria—Temozolomide—malignant glioma	0.00169	0.00458	CcSEcCtD
Guanabenz—Body temperature increased—Temozolomide—malignant glioma	0.00168	0.00456	CcSEcCtD
Guanabenz—Abdominal pain—Temozolomide—malignant glioma	0.00168	0.00456	CcSEcCtD
Guanabenz—Hypersensitivity—Carmustine—malignant glioma	0.00162	0.0044	CcSEcCtD
Guanabenz—Asthenia—Carmustine—malignant glioma	0.00158	0.00428	CcSEcCtD
Guanabenz—Hypersensitivity—Temozolomide—malignant glioma	0.00157	0.00425	CcSEcCtD
Guanabenz—Asthenia—Temozolomide—malignant glioma	0.00153	0.00414	CcSEcCtD
Guanabenz—Diarrhoea—Carmustine—malignant glioma	0.00151	0.00409	CcSEcCtD
Guanabenz—Pruritus—Temozolomide—malignant glioma	0.00151	0.00408	CcSEcCtD
Guanabenz—Dizziness—Carmustine—malignant glioma	0.00146	0.00395	CcSEcCtD
Guanabenz—Diarrhoea—Temozolomide—malignant glioma	0.00146	0.00395	CcSEcCtD
Guanabenz—Dizziness—Temozolomide—malignant glioma	0.00141	0.00382	CcSEcCtD
Guanabenz—Vomiting—Carmustine—malignant glioma	0.0014	0.0038	CcSEcCtD
Guanabenz—Rash—Carmustine—malignant glioma	0.00139	0.00377	CcSEcCtD
Guanabenz—Dermatitis—Carmustine—malignant glioma	0.00139	0.00376	CcSEcCtD
Guanabenz—Headache—Carmustine—malignant glioma	0.00138	0.00374	CcSEcCtD
Guanabenz—Vomiting—Temozolomide—malignant glioma	0.00135	0.00367	CcSEcCtD
Guanabenz—Rash—Temozolomide—malignant glioma	0.00134	0.00364	CcSEcCtD
Guanabenz—Dermatitis—Temozolomide—malignant glioma	0.00134	0.00364	CcSEcCtD
Guanabenz—Headache—Temozolomide—malignant glioma	0.00133	0.00362	CcSEcCtD
Guanabenz—Nausea—Carmustine—malignant glioma	0.00131	0.00355	CcSEcCtD
Guanabenz—Nausea—Temozolomide—malignant glioma	0.00126	0.00343	CcSEcCtD
Guanabenz—ADRA2C—Signaling by GPCR—AKT2—malignant glioma	6.7e-06	0.000591	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—NTRK1—malignant glioma	6.67e-06	0.000588	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—NTRK2—malignant glioma	6.65e-06	0.000585	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—YWHAE—malignant glioma	6.65e-06	0.000585	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—MMP3—malignant glioma	6.64e-06	0.000585	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—PIK3CB—malignant glioma	6.62e-06	0.000583	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—FLT1—malignant glioma	6.62e-06	0.000583	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—DUSP6—malignant glioma	6.59e-06	0.00058	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CDKN2B—malignant glioma	6.58e-06	0.00058	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—PIK3CG—malignant glioma	6.55e-06	0.000577	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—JAG1—malignant glioma	6.5e-06	0.000573	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—KRAS—malignant glioma	6.49e-06	0.000572	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—NOTCH3—malignant glioma	6.48e-06	0.000571	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—PIK3CD—malignant glioma	6.44e-06	0.000568	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—IDH1—malignant glioma	6.4e-06	0.000564	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PTK2—malignant glioma	6.39e-06	0.000563	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—PIK3CA—malignant glioma	6.39e-06	0.000563	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—FBXW7—malignant glioma	6.37e-06	0.000561	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—CXCL8—malignant glioma	6.36e-06	0.00056	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—HES1—malignant glioma	6.28e-06	0.000553	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—BDKRB2—malignant glioma	6.25e-06	0.00055	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—NCOR1—malignant glioma	6.24e-06	0.00055	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—F2—malignant glioma	6.22e-06	0.000548	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—VEGFA—malignant glioma	6.2e-06	0.000546	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MMP3—malignant glioma	6.2e-06	0.000546	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—SPHK1—malignant glioma	6.19e-06	0.000546	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—PIK3CB—malignant glioma	6.18e-06	0.000545	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—TP53—malignant glioma	6.18e-06	0.000544	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—GSTP1—malignant glioma	6.16e-06	0.000543	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—RAF1—malignant glioma	6.16e-06	0.000542	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CDKN2B—malignant glioma	6.15e-06	0.000541	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—IL2—malignant glioma	6.08e-06	0.000536	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CYP2C18—malignant glioma	6.07e-06	0.000535	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—PIK3CB—malignant glioma	6.01e-06	0.00053	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—AKT2—malignant glioma	6e-06	0.000528	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—CAT—malignant glioma	6e-06	0.000528	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PDGFRA—malignant glioma	5.98e-06	0.000527	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PTK2—malignant glioma	5.97e-06	0.000526	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—PIK3CA—malignant glioma	5.96e-06	0.000525	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—PIK3CG—malignant glioma	5.95e-06	0.000524	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—CXCL8—malignant glioma	5.94e-06	0.000523	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—HES1—malignant glioma	5.86e-06	0.000517	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—PTPN11—malignant glioma	5.85e-06	0.000515	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—NCOR1—malignant glioma	5.83e-06	0.000514	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—NOTCH2—malignant glioma	5.81e-06	0.000512	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—SPP1—malignant glioma	5.8e-06	0.000511	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—CXCL8—malignant glioma	5.78e-06	0.000509	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—TP53—malignant glioma	5.77e-06	0.000508	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—PIK3CD—malignant glioma	5.76e-06	0.000508	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—RAF1—malignant glioma	5.75e-06	0.000507	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	5.72e-06	0.000504	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—KNG1—malignant glioma	5.68e-06	0.000501	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—CAV1—malignant glioma	5.68e-06	0.000501	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—IL2—malignant glioma	5.68e-06	0.0005	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—NCOR1—malignant glioma	5.66e-06	0.000499	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—PIK3CB—malignant glioma	5.62e-06	0.000495	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PDGFRA—malignant glioma	5.58e-06	0.000492	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—IL2—malignant glioma	5.52e-06	0.000486	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—TERT—malignant glioma	5.5e-06	0.000485	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—AKT2—malignant glioma	5.45e-06	0.00048	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—SPP1—malignant glioma	5.42e-06	0.000477	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—NTRK1—malignant glioma	5.42e-06	0.000477	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—CXCL8—malignant glioma	5.4e-06	0.000475	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PDGFB—malignant glioma	5.37e-06	0.000473	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—FGFR1—malignant glioma	5.34e-06	0.000471	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—KRAS—malignant glioma	5.27e-06	0.000465	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—HIF1A—malignant glioma	5.26e-06	0.000463	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—PIK3CD—malignant glioma	5.23e-06	0.000461	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—AKT1—malignant glioma	5.22e-06	0.00046	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	5.21e-06	0.000459	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PIK3CG—malignant glioma	5.18e-06	0.000456	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—IL2—malignant glioma	5.16e-06	0.000454	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—TERT—malignant glioma	5.14e-06	0.000453	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CAV1—malignant glioma	5.09e-06	0.000448	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MMP3—malignant glioma	5.04e-06	0.000444	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—KDR—malignant glioma	5.03e-06	0.000443	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	5.03e-06	0.000443	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—PIK3CB—malignant glioma	5.02e-06	0.000442	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PDGFB—malignant glioma	5.01e-06	0.000442	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PPARG—malignant glioma	5e-06	0.00044	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CDKN2B—malignant glioma	4.99e-06	0.00044	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—FGFR1—malignant glioma	4.99e-06	0.00044	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—HIF1A—malignant glioma	4.91e-06	0.000433	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GSTT1—malignant glioma	4.91e-06	0.000432	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—AKT1—malignant glioma	4.87e-06	0.000429	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PTK2—malignant glioma	4.85e-06	0.000427	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—PIK3CA—malignant glioma	4.84e-06	0.000427	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—FN1—malignant glioma	4.84e-06	0.000427	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—F2—malignant glioma	4.84e-06	0.000427	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—CXCL8—malignant glioma	4.83e-06	0.000425	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—BAD—malignant glioma	4.79e-06	0.000422	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—HES1—malignant glioma	4.76e-06	0.00042	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CAV1—malignant glioma	4.75e-06	0.000419	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—NOTCH1—malignant glioma	4.74e-06	0.000417	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—NCOR1—malignant glioma	4.74e-06	0.000417	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—KDR—malignant glioma	4.7e-06	0.000414	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—TP53—malignant glioma	4.69e-06	0.000413	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—RAF1—malignant glioma	4.67e-06	0.000412	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CD80—malignant glioma	4.64e-06	0.000409	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—APC—malignant glioma	4.63e-06	0.000408	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PIK3CG—malignant glioma	4.63e-06	0.000408	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—CAV1—malignant glioma	4.62e-06	0.000407	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—IL2—malignant glioma	4.61e-06	0.000406	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PTGS1—malignant glioma	4.6e-06	0.000405	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	4.58e-06	0.000404	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—EGF—malignant glioma	4.58e-06	0.000404	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—PIK3CB—malignant glioma	4.56e-06	0.000402	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PTPN11—malignant glioma	4.55e-06	0.000401	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PIK3CD—malignant glioma	4.55e-06	0.000401	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PDGFRA—malignant glioma	4.53e-06	0.0004	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—F2—malignant glioma	4.52e-06	0.000399	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—FN1—malignant glioma	4.52e-06	0.000399	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—BAD—malignant glioma	4.47e-06	0.000394	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—NOTCH1—malignant glioma	4.43e-06	0.00039	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—SPP1—malignant glioma	4.4e-06	0.000388	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—CXCL8—malignant glioma	4.38e-06	0.000386	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—BRAF—malignant glioma	4.36e-06	0.000384	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CD80—malignant glioma	4.34e-06	0.000382	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—APC—malignant glioma	4.33e-06	0.000381	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PIK3CG—malignant glioma	4.33e-06	0.000381	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—EGF—malignant glioma	4.28e-06	0.000377	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—BCHE—malignant glioma	4.28e-06	0.000377	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PTPN11—malignant glioma	4.25e-06	0.000375	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—AKT2—malignant glioma	4.24e-06	0.000374	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—SLC5A5—malignant glioma	4.22e-06	0.000372	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—EGFR—malignant glioma	4.22e-06	0.000372	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PIK3CG—malignant glioma	4.21e-06	0.00037	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—IL2—malignant glioma	4.19e-06	0.000369	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—TERT—malignant glioma	4.17e-06	0.000368	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PIK3CD—malignant glioma	4.07e-06	0.000359	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PDGFB—malignant glioma	4.07e-06	0.000359	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—BRAF—malignant glioma	4.07e-06	0.000358	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PPARG—malignant glioma	4.06e-06	0.000358	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—FGFR1—malignant glioma	4.05e-06	0.000357	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—PIK3CA—malignant glioma	4.04e-06	0.000356	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.99e-06	0.000352	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—HIF1A—malignant glioma	3.99e-06	0.000352	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—KRAS—malignant glioma	3.99e-06	0.000351	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PIK3CB—malignant glioma	3.97e-06	0.000349	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—AKT2—malignant glioma	3.96e-06	0.000349	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—AKT1—malignant glioma	3.96e-06	0.000349	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.96e-06	0.000349	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—EGFR—malignant glioma	3.94e-06	0.000347	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PTGS2—malignant glioma	3.93e-06	0.000346	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—FGF2—malignant glioma	3.9e-06	0.000344	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CAV1—malignant glioma	3.86e-06	0.00034	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—KDR—malignant glioma	3.82e-06	0.000336	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PIK3CD—malignant glioma	3.81e-06	0.000335	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—PIK3CA—malignant glioma	3.77e-06	0.000332	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—KRAS—malignant glioma	3.73e-06	0.000328	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PIK3CD—malignant glioma	3.7e-06	0.000326	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—F2—malignant glioma	3.67e-06	0.000324	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—FN1—malignant glioma	3.67e-06	0.000324	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—PIK3CA—malignant glioma	3.66e-06	0.000323	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—MDM2—malignant glioma	3.65e-06	0.000322	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—FGF2—malignant glioma	3.64e-06	0.000321	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—RAF1—malignant glioma	3.64e-06	0.00032	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—BAD—malignant glioma	3.63e-06	0.00032	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—ERBB2—malignant glioma	3.6e-06	0.000317	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—NOTCH1—malignant glioma	3.6e-06	0.000317	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PIK3CB—malignant glioma	3.55e-06	0.000313	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CD80—malignant glioma	3.52e-06	0.00031	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PIK3CG—malignant glioma	3.52e-06	0.00031	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—APC—malignant glioma	3.52e-06	0.00031	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—EGF—malignant glioma	3.48e-06	0.000306	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PTPN11—malignant glioma	3.45e-06	0.000304	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.45e-06	0.000304	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PTEN—malignant glioma	3.43e-06	0.000302	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—PIK3CA—malignant glioma	3.42e-06	0.000302	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CXCL8—malignant glioma	3.41e-06	0.000301	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MDM2—malignant glioma	3.41e-06	0.0003	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GSTP1—malignant glioma	3.4e-06	0.0003	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—RAF1—malignant glioma	3.4e-06	0.000299	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—ERBB2—malignant glioma	3.36e-06	0.000296	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PIK3CB—malignant glioma	3.32e-06	0.000292	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CAT—malignant glioma	3.31e-06	0.000292	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—BRAF—malignant glioma	3.31e-06	0.000291	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—AKT1—malignant glioma	3.3e-06	0.00029	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CASP3—malignant glioma	3.27e-06	0.000288	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IL2—malignant glioma	3.26e-06	0.000287	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PIK3CB—malignant glioma	3.22e-06	0.000284	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—AKT2—malignant glioma	3.22e-06	0.000283	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—EGFR—malignant glioma	3.2e-06	0.000282	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PTGS2—malignant glioma	3.19e-06	0.000281	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CXCL8—malignant glioma	3.19e-06	0.000281	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—NCOR1—malignant glioma	3.13e-06	0.000275	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PIK3CD—malignant glioma	3.09e-06	0.000272	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—MMP9—malignant glioma	3.09e-06	0.000272	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—AKT1—malignant glioma	3.08e-06	0.000271	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PTEN—malignant glioma	3.07e-06	0.00027	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—PIK3CA—malignant glioma	3.06e-06	0.00027	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CASP3—malignant glioma	3.05e-06	0.000269	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IL2—malignant glioma	3.05e-06	0.000268	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—KRAS—malignant glioma	3.03e-06	0.000267	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—AKT1—malignant glioma	2.99e-06	0.000264	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—FGF2—malignant glioma	2.96e-06	0.000261	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MMP9—malignant glioma	2.88e-06	0.000254	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PTEN—malignant glioma	2.87e-06	0.000253	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—AKT1—malignant glioma	2.8e-06	0.000246	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PTEN—malignant glioma	2.78e-06	0.000245	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—PIK3CA—malignant glioma	2.78e-06	0.000245	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—VEGFA—malignant glioma	2.77e-06	0.000244	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MDM2—malignant glioma	2.77e-06	0.000244	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—RAF1—malignant glioma	2.76e-06	0.000243	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—STAT3—malignant glioma	2.74e-06	0.000242	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—ERBB2—malignant glioma	2.73e-06	0.000241	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PIK3CB—malignant glioma	2.69e-06	0.000237	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CXCL8—malignant glioma	2.59e-06	0.000228	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—VEGFA—malignant glioma	2.59e-06	0.000228	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—STAT3—malignant glioma	2.56e-06	0.000226	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—MYC—malignant glioma	2.55e-06	0.000225	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CAV1—malignant glioma	2.55e-06	0.000225	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—AKT1—malignant glioma	2.5e-06	0.00022	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—EGFR—malignant glioma	2.49e-06	0.00022	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CASP3—malignant glioma	2.48e-06	0.000218	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IL2—malignant glioma	2.47e-06	0.000218	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.43e-06	0.000214	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PIK3CA—malignant glioma	2.42e-06	0.000213	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MYC—malignant glioma	2.38e-06	0.00021	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—KRAS—malignant glioma	2.36e-06	0.000208	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MMP9—malignant glioma	2.34e-06	0.000206	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—EGFR—malignant glioma	2.33e-06	0.000205	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PTEN—malignant glioma	2.33e-06	0.000205	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PIK3CG—malignant glioma	2.32e-06	0.000205	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—AKT1—malignant glioma	2.27e-06	0.0002	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PPARG—malignant glioma	2.24e-06	0.000197	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—KRAS—malignant glioma	2.2e-06	0.000194	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PIK3CA—malignant glioma	2.16e-06	0.000191	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—VEGFA—malignant glioma	2.1e-06	0.000185	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—TP53—malignant glioma	2.09e-06	0.000184	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—STAT3—malignant glioma	2.08e-06	0.000183	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PIK3CD—malignant glioma	2.04e-06	0.00018	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PIK3CA—malignant glioma	2.02e-06	0.000178	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—AKT1—malignant glioma	1.98e-06	0.000174	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PIK3CA—malignant glioma	1.96e-06	0.000173	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—TP53—malignant glioma	1.96e-06	0.000172	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MYC—malignant glioma	1.93e-06	0.00017	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—EGFR—malignant glioma	1.89e-06	0.000167	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—KRAS—malignant glioma	1.79e-06	0.000157	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PIK3CB—malignant glioma	1.78e-06	0.000157	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—AKT1—malignant glioma	1.77e-06	0.000156	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PTGS2—malignant glioma	1.76e-06	0.000155	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—AKT1—malignant glioma	1.65e-06	0.000146	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PIK3CA—malignant glioma	1.64e-06	0.000145	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—AKT1—malignant glioma	1.6e-06	0.000141	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—TP53—malignant glioma	1.59e-06	0.00014	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PTEN—malignant glioma	1.54e-06	0.000135	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—AKT1—malignant glioma	1.34e-06	0.000118	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PIK3CA—malignant glioma	1.08e-06	9.55e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—AKT1—malignant glioma	8.86e-07	7.8e-05	CbGpPWpGaD
